Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 20;107(2):393-396.
doi: 10.4269/ajtmh.22-0051. Print 2022 Aug 17.

Fatal Pediatric Melioidosis and the Role of Hyperferritinemic Sepsis-Induced Multiple-Organ Dysfunction Syndrome

Affiliations

Fatal Pediatric Melioidosis and the Role of Hyperferritinemic Sepsis-Induced Multiple-Organ Dysfunction Syndrome

Anand Mohan et al. Am J Trop Med Hyg. .

Abstract

Melioidosis is reported to cause a high fatality rate in children, even in the absence of risk factors for disease. The aim of this study was to identify characteristics of fatal pediatric melioidosis infection. We performed a retrospective analysis of children aged < 15 years with culture-confirmed melioidosis admitted to Bintulu Hospital in Sarawak, Malaysian Borneo, from January 2011 to December 2020. Forty-one children had culture-confirmed melioidosis. Nine (22%) had a fatal outcome; 8 (89%) had no predisposing risk factors. Bacteremia, septic shock, and acute respiratory distress syndrome were present in all fatalities. Demographic characteristics, presenting manifestation, and disseminated infection were not significantly associated with mortality, whereas the presence of splenomegaly, cytopenia, disseminated intravascular coagulation, and hepatobiliary dysfunction, all of which are features of hyperferritinemic sepsis-induced multiple-organ dysfunction syndrome, were associated with mortality. Hyperferritinemic sepsis-induced multiple-organ dysfunction syndrome may be a key component in the pathogenesis of fatal pediatric melioidosis.

PubMed Disclaimer

References

    1. Gassiep I, Armstrong M, Norton R, 2020. Human melioidosis. Clin Microbiol Rev 33: e00006-19. - PMC - PubMed
    1. Currie BJ. et al., 2021. The Darwin Prospective Melioidosis Study: a 30-year prospective, observational investigation. Lancet Infect Dis 11: e0005650. - PubMed
    1. Mohan A. et al., 2017. Pediatric melioidosis in Sarawak, Malaysia: epidemiological, clinical and microbiological characteristics. PLoS Negl Trop Dis 21: 1737–1746. - PMC - PubMed
    1. Alvarez-Hernandez G, Cruz-Loustaunau D, Ibarra JA, Rascon-Alcantar A, Contreras-Soto J, Meza-Radilla G, Torres AG, Estrada-de Los Santos P, 2021. Description of two fatal cases of melioidosis in Mexican children with acute pneumonia: case report. BMC Infect Dis 21: 204. - PMC - PubMed
    1. Katanami Y. et al., 2017. A fatal case of melioidosis with pancytopenia in a traveler from Indonesia. J Infect Chemother 23: 241–244. - PubMed